1 |
10% intravenous immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
2 |
10% liquid formulation of human immunoglobulin |
- |
- |
- |
- |
014 [1] 14 💬 |
3 |
: immunoglobulina umana normale 10% per somministrazione endovenosa |
- |
- |
- |
- |
014 [1] 14 💬 |
4 |
Anti-(human tumor necrosis factor) immunoglobulin g (human-mouse monoclonal ca2 heavy chain) |
- |
- |
- |
- |
271 [1] 271 💬 |
5 |
Anti-human t-lymphocyte immunoglobulin from rabbits |
- |
- |
- |
- |
051 [1] 51 💬 |
6 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
7 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
8 |
Antithymocyte gamma immunoglobulin |
- |
- |
- |
- |
013 [1] 13 💬 |
9 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
10 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
11 |
Biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
12 |
Biological: kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
13 |
Chemical conjugate of recombinant human growth hormone (rhgh) and human immunoglobulin g4 fragment (hmc001) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
14 |
Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
274 [1] 274 💬 |
15 |
Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
274 [1] 274 💬 |
16 |
Freeze-dried sulfonated human normal immunoglobulin (ggs) |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 43, 45 💬 |
17 |
Gammaplex (intravenous immunoglobulin) |
- |
- |
- |
- |
065 [1] 65 💬 |
18 |
Gammaplex, intravenous immunoglobulin |
- |
- |
- |
- |
063 [1] 63 💬 |
19 |
Gb-0998 (intravenous immunoglobulin) |
- |
- |
- |
- |
011 [1] 11 💬 |
20 |
High-dose intravenous immunoglobulin (ivig) |
- |
- |
- |
- |
018 [1] 18 💬 |
21 |
High-dose intravenous immunoglobulin (venoglobulin-ih) |
- |
- |
- |
- |
051 [1] 51 💬 |
22 |
Human immunoglobulin |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
23 |
Human immunoglobulin g |
Human immunoglobulin G |
- |
- |
- |
014 [4] 14, 50, 63, 65 💬 |
24 |
Human normal 10% immunoglobulin for intravenous administration |
- |
- |
- |
- |
014 [1] 14 💬 |
25 |
Human normal 10% immunoglobulin for intravenous administrationn |
- |
- |
- |
- |
014 [1] 14 💬 |
26 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 [9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
27 |
Human normal immunoglobulin (iv) |
Human immunoglobulin G |
- |
- |
- |
011 [4] 11, 14, 63, 65 💬 |
28 |
Human normal immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
050 [2] 50, 65 💬 |
29 |
Human normal immunoglobulin (scig) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
30 |
Human normal immunoglobulin (subcutaneous - intramuscular immunoglobulin) |
Human immunoglobulin G |
- |
- |
- |
065 [1] 65 💬 |
31 |
Human normal immunoglobulin (subcutaneous) |
Human immunoglobulin G |
- |
- |
- |
065 [1] 65 💬 |
32 |
Human normal immunoglobulin for |
Human immunoglobulin G |
- |
- |
- |
065 [1] 65 💬 |
33 |
Human normal immunoglobulin for intravenous (iv) administration |
Human immunoglobulin G |
- |
- |
- |
051 [1] 51 💬 |
34 |
Human normal immunoglobulin for intravenous administration |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 51, 65 💬 |
35 |
Human normal immunoglobulin for intravenous use |
Human immunoglobulin G |
- |
- |
- |
063 [2] 63, 65 💬 |
36 |
Human normal immunoglobulin for intravenous use (ivig) |
Human immunoglobulin G |
- |
- |
- |
065 [1] 65 💬 |
37 |
Human normal immunoglobulin for intrvenous use |
Human immunoglobulin G |
- |
- |
- |
063 [1] 63 💬 |
38 |
Human normal immunoglobulin for subcutaneous administration |
Human immunoglobulin G |
- |
- |
- |
051 [2] 51, 65 💬 |
39 |
Human normal immunoglobulin for subcutaneous administration (igsc) |
Human immunoglobulin G |
- |
- |
- |
065 [1] 65 💬 |
40 |
Human normal immunoglobulin g (igg > 98% purity) |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
41 |
Human normal immunoglobulin g (igg) |
Human immunoglobulin G |
- |
- |
- |
011 [1] 11 💬 |
42 |
Humanized immunoglobulin gamma 1 (igg1) kappa monoclonal antibody |
- |
- |
- |
- |
046 [1] 46 💬 |
43 |
I.v. immunoglobulins |
- |
- |
- |
- |
151 [1] 151 💬 |
44 |
Immunoglobulin |
- |
- |
- |
- |
013 [3] 13, 14, 63 💬 |
45 |
Immunoglobulin (hizentra) |
- |
- |
- |
- |
050 [1] 50 💬 |
46 |
Immunoglobulin g |
- |
- |
- |
- |
011 [7] 11, 13, 14, 49, 50, 63, 65 💬 |
47 |
Immunoglobulin g (ig nextgen 16%) |
- |
- |
- |
- |
065 [1] 65 💬 |
48 |
Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy |
- |
- |
- |
- |
002 [1] 2 💬 |
49 |
Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer |
- |
- |
- |
- |
002 [1] 2 💬 |
50 |
Immunoglobulin g1, anti-(human type i interferon receptor) (human monoclonal medi-546 heavy chain), disulfide with human monoclonal medi-546-chain, dimer |
- |
- |
- |
- |
049 [1] 49 💬 |
51 |
Immunoglobulin intravenous (human) |
- |
- |
- |
- |
065 [1] 65 💬 |
52 |
Immunoglobulin perfusion |
- |
- |
- |
- |
014 [1] 14 💬 |
53 |
Immunoglobulina umana normale per somministrazione endovenosa |
- |
- |
- |
- |
014 [1] 14 💬 |
54 |
Immunoglobuline g |
- |
- |
- |
- |
014 [1] 14 💬 |
55 |
Immunoglobulins |
- |
- |
- |
- |
014 [1] 14 💬 |
56 |
Immunoglobulins intravenous (human) |
- |
- |
- |
- |
065 [1] 65 💬 |
57 |
Immunoglobulins, normal human |
- |
- |
- |
- |
065 [1] 65 💬 |
58 |
Immunoglobulins, normal human, for extravascular adm. |
- |
- |
- |
- |
014 [1] 14 💬 |
59 |
Immunoglobulins, normal human, for intravascular adm. |
- |
- |
- |
- |
014 [2] 14, 15 💬 |
60 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 [8] 13, 14, 35, 38, 39, 49, 51, 309 💬 |
61 |
Intravenous immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
014 [4] 14, 17, 164, 296 💬 |
62 |
Intravenous immunoglobulin infusion |
- |
- |
- |
- |
065 [1] 65 💬 |
63 |
Intravenous immunoglobulins (human immunoglobulins g) |
- |
- |
- |
- |
043 [1] 43 💬 |
64 |
L04aa04 - immunoglobulina antitimocitaria (di coniglio) immunoglobulina di coniglio antitimociti umani thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [1] 13 💬 |
65 |
Normal human immunoglobulin g |
Human immunoglobulin G |
- |
- |
- |
065 [1] 65 💬 |
66 |
Rabbit anti-human thymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
67 |
Rabbit human t lymphocyte immunoglobulin |
Rabbit |
- |
- |
- |
013 [2] 13, 60 💬 |
68 |
Serum bovine immunoglobulin |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
69 |
Subcutaneous immunoglobulin |
- |
- |
- |
- |
014 [1] 14 💬 |
70 |
Subcutaneous immunoglobulins |
- |
- |
- |
- |
011 [1] 11 💬 |
71 |
Symptomatic treatment, steroids, immunosuppressive agents, plasma exchange(pe), intravenous immunoglobulin(ivig) |
Human immunoglobulin G |
- |
- |
- |
011 [1] 11 💬 |